Dyadic International is a biotechnology company focused on developing and optimizing a proprietary platform for producing biologically-based products, including vaccines and therapeutics

The company leverages its advanced genetic engineering and expression technologies to create high-yield, cost-effective solutions for the pharmaceutical and biotech industries. Dyadic collaborates with partners to enhance drug development processes and aims to address significant health challenges through its innovative biomanufacturing capabilities. The organization is committed to advancing sustainable practices in life sciences and improving accessibility to critical medicines globally.